QurAlis
Susannah Slepian Adel, Ph.D., is a Scientist I specializing in discovery at QurAlis, with prior experience as a Scientist I in Biology at Third Rock Ventures. Susannah completed postdoctoral research and a Ph.D. in Neuroscience at Brandeis University from August 2017 to September 2023. Earlier academic achievements include obtaining a Bachelor's Degree in Neuroscience from Brown University between 2011 and 2015, as well as working as a Research Technician at Harvard University and as an Undergraduate Research Assistant at Brown University.
QurAlis
1 followers
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. They are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus their programs on tackling specific disease-causing mechanisms.